Paul Cos
Impact in
- Biochemistry top 0.2%
- Phytochemicals and Antioxidant Activities
- Pharmacology top 0.2%
Papers in
- Biochemistry 27
- Traditional and Medicinal Uses of Annonaceae 24
- Pharmacology 28
- Co-authors
- Louis MaesDirk Vanden BergheLuc PietersArnold VlietinckSandra ApersTess De BruyneM. CalommeTom Coenye
- Journals
- Journal of Ethnopharmacology (18 papers)Planta Medica (15 papers)Antimicrobial Agents and Chemotherapy (11 papers)Molecules (10 papers)Journal of Medicinal Chemistry (8 papers)
- Partner nations
- BelgiumCubaUnited States
In The Last Decade
Paul Cos
298 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Biochemistry 1.0k
- Pharmacology 1.1k
- Food Science 1.8k
- Plant Science 2.7k
- Complementary and alternative medicine 594
Countries citing papers authored by Paul Cos
This map shows the geographic impact of Paul Cos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cos more than expected).
Fields of papers citing papers by Paul Cos
This network shows the impact of papers produced by Paul Cos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cos. The network helps show where Paul Cos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Cos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2019 | 74 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 18 | |
| 16 | 2018 | 193 | |
| 17 | 2018 | 1 | |
| 18 | 2016 | 7 | |
| 19 | 2015 | 10 | |
| 20 | 2014 | 21 |
About Paul Cos
Paul Cos is a scholar working on Biochemistry, Pharmacology, Parasitology, Microbiology and Food Science, having authored 304 papers that have together received 11.9k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (45 papers), Trypanosoma species research and implications (36 papers), Essential Oils and Antimicrobial Activity (34 papers), Bacterial biofilms and quorum sensing (25 papers), Traditional and Medicinal Uses of Annonaceae (24 papers), Natural product bioactivities and synthesis (20 papers), Insect Pest Control Strategies (17 papers) and Phytochemistry and Biological Activities (16 papers). The work is most often cited by research in Biochemistry (1.0k citations), Pharmacology (1.1k citations), Food Science (1.8k citations), Plant Science (2.7k citations) and Complementary and alternative medicine (594 citations). Paul Cos has collaborated with scholars based in Belgium, Cuba and United States. Frequent co-authors include Louis Maes, Dirk Vanden Berghe, Luc Pieters, Arnold Vlietinck, Arnold Vlietinck, Sandra Apers, Tess De Bruyne, M. Calomme, Tom Coenye and Nina Hermans. Their work appears in journals such as Journal of Ethnopharmacology, Planta Medica, Antimicrobial Agents and Chemotherapy, Molecules and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.